Changes in plasma levels or activity of clotting and fibrinolysis factors and platelet aggregation could contribute to the risk of vascular complications of diabetes mellitus: Platelet aggregation with ADP and ristocetin increased in diabetic patients with nephropathy, limb arterial disease and retinopathy.